May 17th, 2022 • News• Uncategorized CMS 2023 Rule is Struck Down, Paysign Continues to Offer Innovation Paysign has an important update regarding the pending CMS Rule for 2023. Today, May 17, 2022, Judge Carl Nichols of the …
May 11th, 2022 • Uncategorized Paysign, Inc. Reports First Quarter 2022 Financial Results HENDERSON, Nev. – May 11, 2022 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid car…
April 28th, 2022 • Blogs The False Promise of Current Drug Pricing Reforms The U.S. healthcare system has become a game of chess with each player strategizing their next move to stay in the game.…
April 26th, 2022 • Uncategorized Paysign to Host First-Quarter 2022 Earnings Call HENDERSON, Nev. – April 26, 2022 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid c…
April 20th, 2022 • Blogs What is the Final Price Rule According to the Centers for Medicare and Medic… Copay accumulator and maximizer programs continue to increase, creating new challenges for payers, manufacturers, and pa…
March 22nd, 2022 • Uncategorized Paysign, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results HENDERSON, Nev. – March 22, 2022 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid c…
March 17th, 2022 • Events We’re Sponsoring Asembia Specialty Pharmacy Summit, May 2-5, Las Vegas… Paysign is thrilled to be a Platinum Sponsor at the upcoming Asembia Specialty Pharmacy Summit, taking place May 2-5 at …
February 23rd, 2022 • News Paysign to Host Fourth-Quarter and Full-Year 2021 Earnings Call HENDERSON, Nev. – February 23, 2022 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepai…
January 4th, 2022 • Blogs Raising the Bar: Paysign’s Pharmacy Discount Program Our article, “Raising the Bar: Paysign’s Pharmacy Discount Program,” appears in the latest issue of The Source Mag…
